Seán Walton

Seán Walton
Seán joined Mewburn Ellis LLP in 1990, qualifying as a Chartered Patent Attorney and a European Patent Attorney in 1994. He joined the partnership in 1996. Seán handles patent work in the biotechnology field in particular immunology, antibody engineering, vaccines, diagnostics, medical devices, especially for drug delivery, and plant biotechnology. Seán has considerable experience of European opposition and appeal procedure and advises in strategic patent portfolio planning and analysis, including for applications and oppositions relating to several of the currently world-leading approved biopharmaceuticals. He has been involved in various UK and US litigation and interference proceedings. His clients include major international, US and European companies, including Big Pharma and biotechnology companies, also smaller growing and start-up companies in the USA, UK and Europe, and research institutions.

Recent Posts

The Pioneering Work of Professor Sir Greg Winter

Seán Walton

Seán Walton
03 Oct 2018

Professor Sir Greg Winter’s pioneering work using phage display for the directed evolution of antibodies has been recognised with a Nobel Prize. Professor.